virus
caus
encephalomyel
infect
neuron
recoveri
infect
requir
noncytolyt
clearanc
viru
nervou
system
avoid
damag
irreplac
cell
sever
murin
model
system
viru
infect
use
identifi
clearanc
mechan
quantit
analysi
sindbi
viru
clearanc
month
show
three
phase
day
clearanc
infecti
viru
continu
presenc
viral
rna
day
decreas
level
viral
rna
day
mainten
viral
rna
low
level
antivir
antibodi
interferong
major
role
clearanc
like
role
igm
well
igg
antibodi
longterm
resid
virusspecif
immun
cell
nervou
system
necessari
prevent
viru
reactiv
rna
virus
caus
encephalomyel
includ
mani
arthropodborn
virus
infect
neuron
termin
differenti
irreplac
cell
essenti
function
nervou
system
recoveri
viral
encephalomyel
requir
immunemedi
viru
clearanc
brain
spinal
cord
process
organ
cell
typedepend
viru
infect
mani
organ
eg
lung
gut
cytotox
process
elimin
infect
cell
effici
mechan
viru
clearanc
infect
cell
target
elimin
cell
replac
quickli
new
uninfect
cell
type
howev
recoveri
neuron
infect
challeng
immun
system
preserv
neuron
function
requir
surviv
infect
cell
noncytolyt
clearanc
process
identifi
vivo
mechan
involv
recoveri
viral
encephalomyel
use
consid
multipl
aspect
clearanc
process
time
frame
develop
innat
adapt
respons
relationship
phase
viru
clearanc
potenti
role
differ
compon
immun
respons
phase
clearanc
infecti
viru
first
step
aspect
clearanc
often
measur
investig
howev
infect
cell
longer
produc
viru
allow
surviv
intracellular
viral
rna
must
also
elimin
clearanc
complet
mechan
prevent
reactiv
viru
replic
must
establish
employ
sindbi
viru
sinv
infect
mice
model
system
understand
recoveri
encephalomyel
relationship
viru
clearanc
neuron
sinv
envelop
plusstrand
rna
viru
geograph
widespread
transmit
mosquito
sinv
caus
rash
arthriti
human
encephalomyel
mice
intracerebr
intranas
inocul
mice
sinv
quickli
spread
throughout
central
nervou
system
cn
viru
replic
mostli
neuron
olfactori
tract
hippocampu
motor
neuron
brainstem
spinal
cord
amount
infecti
viru
brain
spinal
cord
peak
day
infect
clearanc
infecti
viru
initi
day
infect
complet
day
figur
encephalit
virus
primarili
infect
neuron
includ
flaviviru
west
nile
viru
rabi
viru
coronaviru
mous
hepat
viru
mhv
picornaviru
theiler
murin
encephalomyel
viru
tmev
provid
import
mous
model
understand
role
immun
respons
viral
encephalomyel
mhv
tmev
initi
infect
neuron
caus
encephalomyel
virus
subsequ
spread
glial
cell
caus
late
demyelin
diseas
due
persist
viru
infect
clearanc
infecti
viru
virusinfect
cell
must
elimin
complet
clear
infect
matur
neuron
rel
resist
virusinduc
immunemedi
cytolysi
benefici
host
immun
clearanc
mechan
damag
infect
neuron
function
neuron
lost
outcom
viru
infect
caus
neuron
death
infect
cell
allow
surviv
must
mechan
inhibit
intracellular
synthesi
viru
nucleic
acid
protein
elimin
viru
genom
cell
prevent
replac
degrad
sinv
infect
neuron
surviv
clearanc
infecti
viru
mice
recov
infect
unev
howev
take
mani
week
level
viral
rna
cn
decreas
figur
clearanc
process
complet
mechan
prevent
resumpt
viru
replic
need
place
avoid
chronic
progress
relaps
diseas
thu
mous
model
cn
infect
offer
opportun
identifi
multipl
mechan
requir
recoveri
viral
encephalomyel
prevent
chronic
diseas
innat
immun
respons
local
produc
type
interferon
ifn
import
initi
control
viru
replic
ifnb
particularli
import
type
ifn
cn
produc
virusinfect
neuron
ifnbdefici
mice
higher
viru
titer
first
day
infect
nondefici
mice
figur
despit
presenc
high
level
ifna
factor
produc
cn
innat
respons
includ
tnf
induc
glial
cell
activ
express
adhes
molecul
endotheli
cell
cell
migrat
adapt
immun
respons
adapt
immun
respons
initi
drain
cervic
lymph
node
virusspecif
cell
rapidli
expand
acquir
effector
function
begin
enter
circul
b
cell
respons
occur
two
phase
rapid
extrafollicular
cellzon
respons
slower
folliculargermin
center
b
cellzon
respons
extrafollicular
plasmablast
gener
first
phase
prolifer
extens
rapidli
produc
low
affin
antivir
antibodi
predominantli
igm
germin
center
b
cell
undergo
class
switch
recombin
somat
hypermut
select
result
plasmablast
plasma
cell
produc
primarili
high
affin
igg
antibodi
type
antibodysecret
cell
enter
circul
home
site
infect
includ
cn
virusspecif
tlymphocyt
blymphocyt
begin
infiltr
brain
blood
day
infect
earliest
cell
cell
follow
cell
b
cell
figur
clearanc
infecti
viru
begin
figur
cell
virusspecif
effector
phenotyp
cell
enter
parenchyma
cytotox
activ
produc
ifng
cell
accumul
around
vessel
produc
sever
cytokin
includ
ifng
initi
antibodysecret
b
cell
enter
cn
produc
igm
follow
sever
day
later
cell
produc
igg
iga
absenc
adapt
immun
respons
eg
sever
combin
immunodefici
scid
mice
clearanc
figur
local
product
ifna
ifnb
sustain
entri
mononuclear
cell
cn
requir
viru
clearanc
inhibit
cn
inflamm
delay
process
studi
determin
compon
adapt
immun
respons
effect
infecti
viru
clearanc
cn
antivir
antibodi
cell
ifng
identifi
import
contributor
clearanc
neuron
antibodi
studi
use
passiv
transfer
antibodi
persist
infect
scid
mice
shown
igg
antibodi
sinv
glycoprotein
effect
clear
infecti
viru
noncytolyt
process
type
neuron
brain
spinal
cord
antibodi
also
critic
clearanc
rabi
viru
neuron
vitro
studi
mechan
iggmedi
clearanc
shown
antibodi
bind
surfac
infect
cell
block
viru
bud
antibodi
interact
infect
cell
produc
dosedepend
restor
host
protein
synthesi
na
k
atpas
pump
function
membran
potenti
respons
ifnab
first
hour
antibodi
treatment
infect
cell
synthesi
nonstructur
protein
prolong
synthesi
viral
rna
increas
subsequ
decreas
viral
rna
synthesi
requir
bival
antibodi
neither
complement
leukocyt
necessari
antibodymedi
clearanc
cell
cell
infiltr
parenchyma
import
perforindepend
clearanc
wnv
neuron
clearanc
mhv
microgli
cell
astrocyt
macrophag
although
neuron
express
littl
surfac
mhc
class
protein
vivo
imag
shown
cell
interact
directli
tmevinfect
neuron
process
may
mediat
clearanc
damag
ifng
ifng
implic
clearanc
measl
viru
lymphocyt
choriomening
viru
vesicular
stomat
viru
neuron
studi
b
celldefici
mmt
mice
infect
sinv
show
antibodi
requir
clearanc
infecti
viru
brain
spinal
cord
neuron
therefor
mechan
antibodyindepend
clearanc
exist
motor
neuron
hippocamp
cortic
neuron
deplet
either
cell
mmt
mice
impair
viru
clearanc
similar
extent
suggest
overlap
function
like
cytokin
secret
use
cytokineexpress
recombin
virus
show
infecti
sinv
could
clear
local
product
ifng
tnfa
vitro
studi
show
ifng
treatment
persist
infect
differenti
neuron
cell
rapid
profound
effect
infect
cell
neuron
surviv
improv
host
protein
synthesi
restor
viral
rna
synthesi
show
initi
increas
h
treatment
decreas
ratio
genom
subgenom
rna
follow
hour
later
termin
viral
rna
synthesi
suppress
viru
replic
mediat
signal
jakstat
pathway
specif
intracellular
effector
known
gener
nitric
oxid
suggest
infecti
viru
clear
primari
infect
vivo
clearanc
infecti
viru
cn
begin
within
day
infect
complet
day
figur
first
cell
adapt
immun
respons
appear
cn
ifngproduc
cell
follow
ifngproduc
cell
igmproduc
b
cell
figur
three
type
effector
cell
present
cn
clearanc
process
rel
role
cell
subset
cell
vivo
clearanc
infecti
viru
defin
although
igg
antibodi
glycoprotein
effect
clear
infecti
sinv
cn
product
virusspecif
igg
begin
approxim
day
infect
initi
clearanc
day
infect
suggest
import
vivo
role
sinvspecif
igm
rather
igg
studi
antibodymedi
protect
fatal
enceph
suggest
igm
mab
less
protect
igg
mab
similar
specif
igm
plasma
cross
poorli
brain
due
bloodbrain
barrier
size
restrict
protein
entri
therefor
lack
igm
efficaci
compar
igg
passiv
transfer
could
due
ineffici
igm
entri
cn
rather
lack
biolog
activ
studi
rabi
viru
infect
shown
infiltr
antibodysecret
cell
much
effect
viru
clearanc
serum
antibodi
local
antibodi
product
infiltr
igmproduc
extrafollicular
b
cell
plasmablast
may
efficaci
furthermor
sever
line
evid
suggest
local
produc
igm
may
suffici
clearanc
infecti
sinv
cn
celldefici
athym
nunu
mice
produc
virusspecif
igm
cell
littl
igg
abl
clear
cn
viru
normal
kinet
bival
antibodi
requir
suppress
sinv
replic
possibl
multival
igm
antibodi
may
even
effect
igg
infecti
viru
clear
viral
rna
decreas
immunolog
normal
mice
viral
rna
level
gradual
decreas
sever
week
infecti
viru
clear
figur
scid
mice
clear
viru
respons
passiv
transfer
antibodi
viru
replic
renew
brain
mice
antibodi
level
decay
thu
viral
rna
persist
rna
remain
capabl
renew
viru
product
secondari
failur
immun
control
therefor
immunemedi
decreas
viral
rna
second
phase
clearanc
like
particularli
import
prevent
renew
viru
replic
phase
infect
rapid
contract
number
cell
cn
cell
number
maintain
b
cell
number
increas
figur
mice
defici
ifng
respons
ifng
often
display
transient
reactiv
viru
product
day
infect
figur
suggest
ifng
need
continu
decreas
level
viral
rna
possibl
cell
provid
earli
local
ifng
product
cell
essenti
continu
local
product
ifng
potenti
provid
local
help
maintain
cell
function
antibodi
product
b
cell
antibodi
produc
cn
phase
clearanc
high
avid
igg
iga
may
also
regul
intracellular
product
viral
rna
recoveri
immun
cell
still
maintain
cn
approxim
month
infect
viral
rna
cn
decreas
stabl
low
level
figur
cell
express
integrin
maintain
independ
homeostat
prolifer
cn
prolong
period
time
cn
infect
b
cell
secret
virusspecif
antibodi
also
present
stabl
low
level
local
antibodi
synthesi
continu
within
infect
cn
mani
month
evid
suggest
antibodi
essenti
prevent
recrudesc
viru
replic
longterm
intrathec
product
virusspecif
antibodi
character
recoveri
phase
viral
enceph
human
well
mice
evid
import
sustain
suppress
viru
replic
cn
come
clinic
experi
use
rituximab
elimin
b
cell
treatment
b
cell
lymphoma
autoimmun
diseas
natalizumab
prevent
entri
inflammatori
cell
cn
major
complic
treatment
reactiv
viru
infect
cn
b
cell
product
antivir
antibodi
cellproduct
ifng
within
infect
nervou
system
import
noncytolyt
clearanc
infecti
viru
viral
rna
also
prevent
viru
reactiv
howev
mani
aspect
vivo
clearanc
understood
includ
role
igm
earli
clearanc
infecti
viru
mechan
product
viral
rna
suppress
neuron
longer
produc
infecti
viru
environ
brain
support
longterm
resid
immun
cell
region
infect
